Tiiu Kullisaar,Mihkel Zilmer,Imbi Smidt,Kersti Zilmer,Marika Mikelsaar,Pirje Hütt
申请号：
US14655328
公开号：
US20150343003A1
申请日:
2013.12.20
申请国别(地区):
US
年份:
2015
代理人:
摘要：
The invention provides a composition comprising Lactobacillus fermentum ME-3 strain DSM 14241 for use in preventing, alleviating the symptoms of or treating, alone or as an adjuvant component, a metabolic syndrome related disorder selected from prediabetes, type 2 diabetes and cardiovascular disease. The effect may be achieved by simultaneously: decreasing the level of glycated haemoglobin HbA1c, decreasing or preventing low-grade inflammation on a cellular level and increasing the level of adiponectin.
